Androgen insensitivity syndrome: Difference between revisions
No edit summary |
|||
Line 45: | Line 45: | ||
==Treatment== | ==Treatment== | ||
[[Androgen insensitivity syndrome medical therapy|Medical Therapy]] | [[Androgen insensitivity syndrome surgery|Surgery]] | [[Androgen insensitivity syndrome primary prevention|Primary Prevention]] | [[Androgen insensitivity syndrome secondary prevention|Secondary Prevention]] | [[Androgen insensitivity syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Androgen insensitivity syndrome future or investigational therapies|Future or Investigational Therapies]] | [[Androgen insensitivity syndrome medical therapy|Medical Therapy]] | [[Androgen insensitivity syndrome surgery|Surgery]] | [[Androgen insensitivity syndrome primary prevention|Primary Prevention]] | [[Androgen insensitivity syndrome secondary prevention|Secondary Prevention]] | [[Androgen insensitivity syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Androgen insensitivity syndrome future or investigational therapies|Future or Investigational Therapies]] | ||
==Related Chapters== | |||
* 17-hydroxylase deficiency syndrome | |||
* 3-beta-hydroxysteroid dehydrogenase deficiency | |||
* [[5-alpha-reductase deficiency]] | |||
* [[Congenital adrenal hyperplasia]] | |||
* Mayer-rokitansky syndrome | |||
Revision as of 07:23, 31 August 2012
Androgen insensitivity syndrome | |
Testosterone (structure pictured) and dihydrotestosterone to a lesser degree, are the primary androgens involved in AIS. | |
ICD-10 | E34.5 |
ICD-9 | 259.5 |
OMIM | 312300 300068 |
DiseasesDB | 29662 Template:DiseasesDB2 |
MeSH | D013734 |
Androgen insensitivity syndrome Microchapters |
Differentiating Androgen insensitivity syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Androgen insensitivity syndrome On the Web |
American Roentgen Ray Society Images of Androgen insensitivity syndrome |
Directions to Hospitals Treating Androgen insensitivity syndrome |
Risk calculators and risk factors for Androgen insensitivity syndrome |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Androgen resistance syndrome; complete androgen insensitivity; Goldberg-Morris syndrome; testicular feminization syndrome; incomplete androgen insensitivity; partial androgen insensitivity; Reifenstein syndrome; Gilbert-Dreyfus syndrome
Overview
Historical Perspective
Pathophysiology
Differentiating Androgen insensitivity syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
- 17-hydroxylase deficiency syndrome
- 3-beta-hydroxysteroid dehydrogenase deficiency
- 5-alpha-reductase deficiency
- Congenital adrenal hyperplasia
- Mayer-rokitansky syndrome